Nature's Sunshine cuts 2026 sales and EBITDA outlook after weak third quarter

Nature's Sunshine Products reported third quarter 2026 results on November 4, 2026 for the period ended September 30, 2026. Net sales were down 9% to $116.6 million compared to $128.3 million, or down 7% in constant currency.¹ GAAP net income attributable to common shareholders was $1.9 million, or $0.11 per diluted common share, compared to $5.3 million, or $0.30 per diluted common share, a year earlier.¹ Adjusted EBITDA was $11.1 million compared to $15.2 million in the year-ago quarter.¹

CEO Ken Romanzi said the quarter's results were disappointing and fell short of expectations, with particular challenges in China and in the company's Digital business.¹ He said operational disruptions in China have had a larger than anticipated impact on the company's consultant leadership base, which it has begun rebuilding.¹

By region, Asia net sales fell 14.9% to $55.1 million, Europe was roughly flat at $22.1 million, North America fell 6.1% to $34.0 million, and Latin America and Other rose 3.4% to $5.5 million.¹

Citing a stronger U.S. dollar and recent challenges in the China market, the company now expects full year 2026 net sales of $460 to $470 million, down from a prior range of $490 to $500 million, and adjusted EBITDA of $44 to $48 million, down from a prior range of $48 to $52 million.¹

On the balance sheet, as of September 30, 2026, the company had cash and cash equivalents of $89.4 million and zero debt.¹ Net cash provided by operating activities was $9.7 million for the nine months ended September 30, 2026, compared to $25.4 million in the prior year period.¹ During the nine months ended September 30, 2026, the company repurchased 345,000 shares at a total cost of $6.1 million, or $17.66 per share.¹